肝细胞癌:病变发生,分子机制和治疗进展
Zhixian Ding1,2, Lusheng Wang1,2, Jiting Sun1,2
1General Clinical Research Center, Wanbei Coal-Electricity Group General Hospital, Suzhou, China.
Frontiers in oncology
|April 23, 2025
概括
肝细胞癌 (HCC) 的发病包括复杂的遗传和环境因素. 这篇评论探讨了HCC病因,分子途径,免疫功能障碍和包括传统中医 (TCM) 在内的新疗法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 是一种常见的恶性瘤,具有复杂的多因素病因.
- 风险因素包括病毒性肝炎,酒精消费和肝硬化.
- HCC的发展涉及异常的分子信号,分化,血管新生和免疫功能障碍.
研究的目的:
- 审查HCC的多面性质,包括其病因及其分子信号通路.
- 检查免疫失调在HCC进展中的作用.
- 讨论新兴的治疗策略和传统中医药 (TCM) 单体的潜力.
主要方法:
- 对HCC病因学,病变发生和分子机制的文献综述.
- 对免疫系统参与HCC进展的分析.
- 探索新的治疗干预措施,包括免疫疗法和TCM.
主要成果:
- HCC的发病是由复杂的遗传和环境相互作用驱动的.
- 分子信号通路和免疫功能障碍对HCC发育至关重要.
- 新兴疗法显示出对HCC治疗的前景.
结论:
- 对HCC病因学和分子通路的全面了解至关重要.
- 针对免疫失调和探索TCM提供潜在的治疗途径.
- 需要进一步的研究来开发有效的HCC治疗方法.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
1.4K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
